Hematopoietic Effect of Phellinus linteus Polysaccharide in Mouse Splenocytes and Bone Marrow Cells

  • Won, Tae-Joon (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Kim, Min-Soo (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Woo, Jong-Shick (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Han, Sang-Beom (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Hwang, Kwang-Woo (Department of Immunology, College of Pharmacy, Chung-Ang University)
  • Published : 2007.12.31


In anti-cancer therapies, radiotherapy and chemotherapy show a superior inhibition effect on cancer cell growth, but those are very toxic to normal tissues and organs. Particularly, drugs for neutropenia, one of chemotherapy agents, which suppress the function of bone marrow, are needed to be controlled in terms of their dosage and therapy period because of their side effect. Phellinus linteus polysaccharide (PL) has been reported to increase the number of splenocytes and bone marrow cells. PL has been shown to decrease the side effects of cyclophosphamide (CYC) treatment to the cancer patients. PL showed no effects in semisolid clonogenic assay, suggesting that PL doesn't contain substantial compounds to substitute for colony stimulating factors (CSFs). On the other hand, PL increased the expression of SCF, IL-3, GM-CSF, TPO genes. These results indicate that PL may promote the growth and proliferation of splenocytes and bone marrow cells through indirect or CSFs-dependent pathway, which may lead to a hematopoiesis.


  1. Arai, K., Lee, F., Miyajima, A., Miyatake, S., Arai, N. and Yokota, T. (1990). Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59, 783-836
  2. Bociek, R. G. and Armitage, J. O. (1996). Hematopoietic growth factors. CA Cancer J. Clin. 46, 165-184
  3. Bokemeyer, C., Kuczyk, M. A., Kohne, H., Einsele, H., Kynast, B. and Schmoll, H. J. (1996). Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy. Ann. Hematol. 72, 1-9
  4. Browder, I. W. (1983). Role of immunomudulation in surgical infection. Surv. Immunol. Res. 2, 299-301
  5. Brugger, W., Mocklin, W., Heimfeld, S., Berenson, R. J., Mertelsmann, R. and Kanz, L. (1994). Ex vivo expansion of enriched peripheral blood $CD34^+$ progenitor cells by stem cell factor, $interleukin-1{beta}(IL-1{beta})$, IL-6, IL-3, $interferon-{ gamma}$, and erythropoietin. Blood 81, 2579-2584
  6. Cascinu, S. (1995). Management of diarrhea induced by tumors or cancer therapy. Curr. Opin. Oncol. 7, 325-329
  7. Chauvergne. J., Chinet-Charrot, P., Stockle, E., Thomas, L. and Toulouse, C. B. (1996). Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer. Bull. Cancer 83, 315-323
  8. Chihara, G., Hanuram, J., Maeda, Y., Arai, Y. and Fukuoka, F. (1969). Antitumor polysaccharide derive chemically from natural glucan (pachyman). Nature 225, 943-944
  9. Chung, K. S., Kim, S. S., Kim, H. S., Han, M. W. and Kim, B. K. (1994). Antitumor activity of Kp, a protein-polysaccharide from the mycelial culture of Phellinus linteus. Chem. Pharm. Bull. 44, 1093-1095
  10. Clark, S. C. and Kamen, R. (1987). Hematopoietic growth factors as therapeutic agents. Science 236, 1229-1237
  11. Dexter, T. M., Allen, T. D. and Lajtha, L. G. (1997). Conditions controlling the proliferation of hematopoietic stem cells in vitro. J. Cell. Physiol. 91, 335-344
  12. Hirose, K. and Matsushima, K. (1993). The biological significance of the induction of mangnanse superoxide dismutase by interleukine 1 and tumor mecrosis factor. Free Radic. Clin. Med. 7, 71
  13. Ikegawa, T., Nakanishi, M., Uehara, N. and Chihara, G. (1968). Antitumor action of some basidomycetes, especially Phellinus linteus. Gann. 59, 155-157
  14. Ito, I., Inoue, T., Miyaishi, K., Mitsuhashi, N., Kimura, M., Takahashi, I., Maehara, Y. and Niibe, H. (1979). Radiotherapy of the esophageal cancer: initial radiation effect and prognosis on the basis of radiographic findings and histological subclassification types of squamous cell carcinoma. Rinsho Hoshasen 24, 915-921
  15. Jan, W., Visser-Dries, M. and Mulder, H. (1991). Culture of hematopoietic stem cell purified from murine bone marrow. Semin. Hematol. 28, 117-125
  16. Kao, I., Kobayashi, S., Yokokura, T. and Mutai, M. (1981). Antitumor activity of Lactobacillys casei in mice. Gann. 72, 517- 523
  17. Kim, H. M., Han, S. B., Oh, G. T., Kim, Y. H., Hong, D. H., Homg, N. D. and Yoo, I. D. (1996). Stimulation of humoral and cell mediated immunity by polysacchride from mushroom Phellinus linteus. Int. J. Immunopharmacol. 18, 295-303
  18. Mansell, P. W. A., Ichinose, H., Reed, R. H., Krementz, E. T., Mcnamee, R. and Di Luzio Jr, R. (1975). Macrophage-mediated destruction of human malignant cells in vitro. J. Natl. Cancer. Inst. 54, 571-580
  19. Naglieri, E., Gebbia, V., Durini, E., Lelli, G., Abbate, I., Selvaggi, F. P., Di Tonno, P. and Colucci, G. (1998). Standard interleukin-2(IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immunochemotherapeutic association in metastatic renal cell carcinoma. Anticancer Res. 18, 2021-2026
  20. Pronk, L. C., Stoter, G. and Verweij, J. (1995). Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects. Cancer Treat. Rev. 21, 463- 478
  21. Pyo, M. Y., Hyun, S. M. and Yang, K. S. (2001). Effect of Phellinus linteus Extracts on the Humoral Immune Responsc in Normal and Cyclophosphamide-treated mice. J. Appl. Pharmcol. 9, 194-200
  22. Rhee, Y. K., Han, M. J., Park, S. Y. and Kim, D. H. (2000). In vitro and in vivo antitumor activity of the fruit body of Phellinus linteus. Korea J. Food Sci. Technol. 32, 477-480
  23. Ridolfi, R., Flamini, E., Riccobon, A., De Paola, F., Maltoni, R., Gardini, A., Ridolfi, L., Medri, L., Poletti, G. and Amadori, D. (1998), Adjuvant adoptive immunotherapy with tumor-infiltrating lymphocytes and modulated doses of interleukin-2 in 22-patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients. Cancer Immunol. Immunother. 46, 185-193
  24. Sugiura, M. and Ito, H. (1977). Toxicological studies of Ganderma lucidum Karst. Tokyo Yakakyu Daigaku Kenkyu Nempo 27. 722-725
  25. Takeda, T., Shibata, S. and Fukuoka, F. (1969). Further investigation of the structure and the antitumor activity of the polysaccharides from Gyrophora esculenta and Lasallia papulosa. Chem. Pharm. Bull. 17, 1910-1916